期刊
MEDCHEMCOMM
卷 8, 期 1, 页码 53-66出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c6md00394j
关键词
-
资金
- Fundacao para a Ciencia e Tecnologia (FCT) [SFRH/BPD/100434/2014]
- Research Center Grant Centre for Biomedical Research [UID/BIM/04773/2013, 1334]
- Norwegian Research Council
- Norwegian Cancer Society and Helse Vest Health Authority
- ProRegem grant [PD/BD/114258/2016]
- Fundação para a Ciência e a Tecnologia [UID/BIM/04773/2013, SFRH/BPD/100434/2014] Funding Source: FCT
Intrinsic and acquired resistance to conventional and targeted therapeutics is a fundamental reason for treatment failure in many cancer patients. Targeted approaches to overcome chemoresistance as well as resistance to targeted approaches require in depth understanding of the underlying molecular mechanisms. The anti-cancer activity of a drug can be limited by a broad variety of molecular events at different levels of drug action in a cell-autonomous and non-cell-autonomous manner. This review summarizes recent insights into the adaptive mechanisms used by tumours to resist therapy including cellular phenotypic plasticity, dynamic alterations of the tumour microenvironment, activation of redundant signal transduction pathways, modulation of drug target expression levels, and exploitation of pro-survival responses.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据